MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
3717.13%
Quick Ratio
3717.13%
Cash Ratio
225.42%
Debt to Asset Ratio
4.28%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Cash and cash equivalents
Operating lease right-of-use ass...
Others
Liabilities Breakdown
Additional paid-in-capital
Accumulated deficit
Operating lease liabilities, net...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
14,711
20,158
75,603
42,633
Marketable securities
221,840
226,170
187,293
139,774
Prepaid expenses and other current assets
6,029
6,636
5,021
2,520
Total current assets
242,580
252,964
267,917
184,927
Property and equipment, net
929
1,057
830
880
Other long-term assets
364
312
256
266
Operating lease right-of-use assets
6,494
7,016
7,639
4,774
Total assets
250,367
261,349
276,642
190,847
Accounts payable
505
1,495
1,016
786
Accrued expenses
3,628
2,859
6,387
4,098
Current portion of operating lease liabilities
2,393
2,303
2,341
1,477
Total current liabilities
6,526
6,657
9,744
6,361
Operating lease liabilities, net of current portion
4,181
4,651
5,909
4,016
Total liabilities
10,707
11,308
15,653
10,377
Common stock-Common Class A
33
32
31
23
Common stock-Common Class B
5
5
6
6
Additional paid-in-capital
447,185
442,093
438,072
342,400
Accumulated deficit
-206,990
-191,836
-177,380
-162,224
Accumulated other comprehensive income (loss)
-573
-253
260
265
Total stockholders' equity
239,660
250,041
260,989
180,470
Total liabilities and stockholders' equity
250,367
261,349
276,642
190,847
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$221,840K
(43.40%↑ Y/Y)
Cash and cash
equivalents
$14,711K
(-29.22%↓ Y/Y)
Prepaid expenses and
other current assets
$6,029K
(344.94%↑ Y/Y)
Total current assets
$242,580K
(37.18%↑ Y/Y)
Operating lease
right-of-use assets
$6,494K
(29.70%↑ Y/Y)
Property and equipment,
net
$929K
(8.53%↑ Y/Y)
Other long-term
assets
$364K
(95.70%↑ Y/Y)
Total assets
$250,367K
(36.90%↑ Y/Y)
Total liabilities and
stockholders' equity
$250,367K
(36.90%↑ Y/Y)
Total stockholders'
equity
$239,660K
(39.83%↑ Y/Y)
Total liabilities
$10,707K
(-6.88%↓ Y/Y)
Accumulated deficit
-$206,990K
(-38.52%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$573K
(-489.80%↓ Y/Y)
Additional
paid-in-capital
$447,185K
(39.46%↑ Y/Y)
Total current
liabilities
$6,526K
(-9.54%↓ Y/Y)
Operating lease
liabilities, net of current...
$4,181K
(-2.40%↓ Y/Y)
Common stock-Common
Class A
$33K
(73.68%↑ Y/Y)
Common stock-Common
Class B
$5K
(-28.57%↓ Y/Y)
Accrued expenses
$3,628K
(-3.18%↓ Y/Y)
Current portion of
operating lease...
$2,393K
(63.23%↑ Y/Y)
Accounts payable
$505K
(-74.76%↓ Y/Y)
Buy us a coffee
Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM)